Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by Sarb99on Oct 11, 2020 3:34pm
295 Views
Post# 31702724

Guesstimates or Hype vs realistic revenue projection

Guesstimates or Hype vs realistic revenue projection Hmmm first day, first post and started joking Lol…

Monthly, Yearly, or 3-year revenue projection is no joke instead is essential part of any business planning. We have no problem following your estimate of .80 cents per share, but can you please explain how did you get these numbers? Or did you pull your Guesstimates of .80 cents per share out of thin air. https://questcapinc.com/collection-site/
 
Here is our realistic revenue projection for nest year.
QuestCap is launching 180 covid-19 testing centres (cubes). Each of these lab sites are designed to have capacity for up to 150 tests per day, per site, and will charge between $59 (U.S.) and $139 (U.S.) for antibody and antigen tests. https://www.stockwatch.com/News/Item?bid=Z-C:QSC-2972459&symbol=QSC&region=C
 
180 covid-19 testing centres performing 150 test per site, each day. 180x150=27000 test each day.
  • Say 17000 antibody test at $59 USD comes to 17000x59= $1,003,000
  • Say 10000 antibody test at $139 USD comes to 10000x59= $1,390,000
So daily revenue should be $2,393,000 and monthly $71,790,000 they yearly $861,480,000 Then convert all this revenue from USD to CAD with 1.30 and comes to $1,119,924,000 which at 40% profit margin comes to $447,969,600
 
These numbers are in the best scenario and we are talking about buying stock not business itself. So, we want to minimize the risk. We can say collection sites only performed 60-70% of the possible capacity. It also covers if collection sites are busy till March-April then slow down. Accordingly, we should adjust profit from $447,969,600 then just take 60% of this which is realistic $268,781,760. Now you can calculate P/E ratio, here is the method https://www.wealthsimple.com/en-ca/learn/price-earnings-ratio
 
Now talk about other investments QuestCap Made.
 
  1. As of now problem is not covid-19 testing kits, 100’s are approved by FDA. Main problem is testing labs as almost all of the approved testing kits need a lab to perform these covid-19 tests. If anyone notice after launch of these (cubes) testing centres QuestCap is offering Lab service to perform these tests with little competition.
  2. QuestCap already sold $3 million USD testing kits to lab in Columbia S.A https://stockhouse.com/news/press-releases/2020/08/28/mtjr-sells-750-000-covid-19-igg-igm-antibody-tests-in-colombia
  3. QuestCap application for Health Canada should be approved soon as Lyher 2019-Ncov Igm/Igg Antibody Test Kit, One Step Rapid Test Device is under Review for Health Canada approval since July 29, 2020 (over 2 months) here is cached page from July 29th https://web.archive.org/web/20200729094345/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/medical-devices/testing/applications.html
  4. QuestCap Acquire 28% Interest in Colombian Full-Service Medical Clinic called Sanaty IPS S.A.S. and Sanaty is performing covid-19 testing in Columbia S.A. and buying those covid-19 testing kits from QuestCap. So, they get wholesale profit and 28% profit from the retail. https://www.facebook.com/ipssanaty
  5. QuestCap made 500k invest in Sinai Health Foundation to develop testing.  It seems they are developing self testing at home and already running a trial https://www.lunenfeld.ca/shawl/files/file/SHAWL-1%20Information%20Slides_2020Aug25(1).pdf All kind of Govt involved in this study and also have a look at researcher involved in this study at bottom of the slide.
  6. QuestCap Made $1 million investment in Sunnybrook Hospital to Research on covid-19 vaccine. Dr Samira Mubareka is working hard to achieve that https://theconversation.com/training-our-immune-systems-why-we-should-insist-on-a-high-quality-covid-19-vaccine-146650
  7. QuestCap also invested in Amino Therapeutics is currently focused on developing biologic therapeutics for COVID-19. Amino’s research targets small molecule drug candidates and targeted drug delivery systems to transport biologics into the cytosol.
 
Anybody buying or selling any stock need to do their own due diligence. Only you can make best decision for yourself, no one else can do it for you.

Icow33 wrote:

I suppose guesstimate is the best word for this, as no one can ever really know where these things will go...

but what are your thoughts on what this share can achieve? I see lots of people joking about $3-$5, which would be lovely but is dreadfully unrealistic. What about something like $0.80 though?


I mean, who doesn't want to be a millionaire, but a modest 500% gain wood still be nice!


looking forward to your thoughts. 



<< Previous
Bullboard Posts
Next >>